RSC
TMO icon

Red Spruce Capital’s Thermo Fisher Scientific TMO Stock Holding History

Red Spruce Capital’s Portfolio TMO Stock Details TMO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$253K Hold
504
– – 0.09% 91
2026
Q1 		$248K Hold
504
– – 0.1% 91
2025
Q4 		$292K Hold
504
– – 0.12% 86
2025
Q3 		$244K Hold
504
– – 0.1% 89
2025
Q2 		$204K Hold
504
– – 0.09% 90
2025
Q1 		$251K Sell
504
-1,333
-73% -$722K 0.12% 84
2024
Q4 		$956K Buy
1,837
+311
+20% +$171K 0.42% 66
2024
Q3 		$944K Hold
1,526
– – 0.43% 66
2024
Q2 		$844K Buy
1,526
+75
+5% +$43K 0.39% 69
2024
Q1 		$843K Buy
1,451
+21
+1% +$11.8K 0.39% 69
2023
Q4 		$759K Buy
1,430
+31
+2% +$15K 0.39% 69
2023
Q3 		$708K Buy
1,399
+8
+0.6% +$4.26K 0.4% 66
2023
Q2 		$726K Buy
1,391
+112
+9% +$60.4K 0.39% 70
2023
Q1 		$737K Buy
1,279
+16
+1% +$9.02K 0.43% 68
2022
Q4 		$696K Hold
1,263
– – 0.44% 63
2022
Q3 		$641K Buy
1,263
+37
+3% +$20.7K 0.45% 63
2022
Q2 		$666K Sell
1,226
-23
-2% -$12.7K 0.44% 66
2022
Q1 		$738K Buy
1,249
+179
+17% +$103K 0.42% 70
2021
Q4 		$714K Hold
1,070
– – 0.39% 75
2021
Q3 		$611K Buy
1,070
+13
+1% +$7.13K 0.36% 77
2021
Q2 		$533K Buy
1,057
+19
+2% +$8.96K 0.31% 81
2021
Q1 		$474K Buy
1,038
+45
+5% +$21.5K 0.3% 80
2020
Q4 		$463K Buy
993
+79
+9% +$37K 0.32% 79
2020
Q3 		$404K Hold
914
– – 0.33% 75
2020
Q2 		$331K Buy
914
+20
+2% +$6.7K 0.28% 77
2020
Q1 		$254K Buy
+894
New +$282K 0.26% 77

Other funds holding TMO

Swedbank
Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return
Ninety One (UK)
Ninety One (UK) London, United Kingdom $44.7B AUM 17.24% 1-Year Est. Return
Robeco Institutional Asset Management
Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return
Handelsbanken Fonder
Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return
LT
Lindsell Train London, United Kingdom $2.63B AUM 2.97% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return
CF
Canoe Financial Calgary, Alberta, Canada $8.07B AUM 25.47% 1-Year Est. Return
SP
Sarasin & Partners London, United Kingdom $8.54B AUM 9.6% 1-Year Est. Return
DLA
Douglas Lane & Associates New York $7.37B AUM 21.9% 1-Year Est. Return
PL
Perpetual Ltd Sydney, New South Wales, Australia $7B AUM 19.75% 1-Year Est. Return

Red Spruce Capital's TMO Position: Q2 2026 in Review

Red Spruce Capital held its Thermo Fisher Scientific (TMO) position steady in Q2 2026 at 504 shares worth $253K. The position accounts for 0.09% of the portfolio, ranked #91.

Red Spruce Capital first reported a position in TMO in Q1 2020 and has held it in 26 quarters since. The position peaked at $956K in Q4 2024. 567 funds tracked by Wall St. Rank hold TMO as of Q2 2026.

  • Red Spruce Capital held 504 shares of Thermo Fisher Scientific worth $253K as of Q2 2026.
  • Red Spruce Capital left its Thermo Fisher Scientific share count unchanged in Q2 2026.
  • Thermo Fisher Scientific made up 0.09% of Red Spruce Capital's portfolio in Q2 2026, its #91 holding.
  • Red Spruce Capital first reported a position in Thermo Fisher Scientific in Q1 2020 and has held it in 26 quarters since.
  • Red Spruce Capital's Thermo Fisher Scientific position peaked at $956K in Q4 2024.
  • 567 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q2 2026.

Based on Red Spruce Capital's 13F filing for Q2 2026, filed 7 Jul 2026.